Isoquinolines

May 20, 2020

European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat

Sep 20, 2019

Evrenzo® (roxadustat) Tablets Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients

Sep 03, 2019

Rho kinase inhibitor, "Ripasudil Hydrochloride Hydrate" IND application for Phase 2 clinical study in the United States Indication for Corneal Endothelial Diseases [Developmental code: K-321]

Feb 06, 2019

Biotechnology Companies See Growth in Optic Treatment Sectors

Oct 16, 2018

Catalent and Verastem Oncology Partner on Newly Launched, FDA Approved COPIKTRA(TM) (duvelisib) Capsules

Oct 01, 2018

Infinity Pharmaceuticals Earns $22 Million Payment From Verastem Oncology For FDA Approval Of COPIKTRA(TM) (duvelisib) And Updates 2018 Financial Guidance

Aug 07, 2018

Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results

Jun 22, 2018

Biotech's Making Great Progress

May 08, 2018

Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results

Jan 08, 2018

Infinity Provides Update on IPI-549 Phase 1/1b Study, 2018 Goals and Financial Guidance

Nov 07, 2017

Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results